mRNA疫苗的共同临床和免疫特征:比较性临床研究的初步结果
Carlos Fierro1, Nelia Sanchez-Crespo2, Daniel Makrinos3
1Johnson County Clin-Trials, Clinical Research, Lenexa, KS, United States.
Frontiers in immunology
|April 25, 2025
概括
在一项第一阶段试验中,四种mRNA疫苗显示出可接受的反应性和免疫性. 观察到的反应性可能来自mRNA脂质纳米粒子 (LNP) 平台的共同特征.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
- 分子机制的分子机制
背景情况:
- 临床试验往往忽略了疫苗反应背后的分子机制.
- 了解疫苗免疫性和反应性对于开发至关重要.
研究的目的:
- 评估四种mRNA疫苗的反应性和免疫性.
- 探索有助于疫苗反应的分子机制.
- 确定共享和独特的临床和免疫学特征.
主要方法:
- 一个开放的,第一阶段的试验,涉及健康的成年人 (18-75岁).
- 参与者接受了mRNA-1273.222 (COVID-19),mRNA-1345 (RSV),mRNA-1010 (流感) 或FLUAD (流感比较剂) 的单剂量或mRNA-1647 (CMV) 的多剂量.
- 评估了安全性,反应性,幽默免疫性 (中和抗体) 和探索性T细胞和细胞因子反应.
主要成果:
- 所有mRNA疫苗都表现出可接受的反应性,具有轻度至中度的不良反应.
- 在单剂量疫苗接种组中,中和抗体标位在29日增加了2至8倍.
- mRNA疫苗诱导了抗原特异的T1偏差T细胞反应和特定细胞因子和炎症媒介的水平升高.
结论:
- 四种mRNA疫苗表现出可接受的反应性和免疫性.
- 血清生物标志物的变化表明接种疫苗后的先天免疫激活.
- mRNA疫苗的反应性可能与脂质纳米粒子 (LNP) 输送平台有关.
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...